Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fabrice Andre

Showing results (91-100 of 141) with videos related to

Pageof 15
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2010
Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancersGiampaolo Bianchini, Yuan Qi, Ricardo H Alvarez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineLyndsay N Harris, Nofisat Ismaila, Lisa M McShane, et al.
JCO Precision Oncology|January 18, 2024
Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) TrialIan E Krop, Lorenza Mittempergher, Joseph N Paulson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2022
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline UpdateFabrice Andre, Nofisat Ismaila, Kimberly H Allison, et al.
Journal of the National Cancer Institute|December 31, 2010
Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancerTakayuki Iwamoto, Giampaolo Bianchini, Daniel Booser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast CancerCharlotte Fribbens, Ben O'Leary, Lucy Kilburn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancerRoman Rouzier, Lajos Pusztai, Suzette Delaloge, et al.
British Journal of Cancer|January 5, 2024
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestaneHélène Vanacker, Isabelle Treilleux, Camille Schiffler, et al.
Autophagy|October 29, 2015
Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancerSylvain Ladoire, Frédérique Penault-Llorca, Laura Senovilla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2026
DESTINY-Breast08: a phase 1b study of trastuzumab deruxtecan in combination with other anticancer therapies in patients with HER2-low metastatic breast cancerKomal Jhaveri, Sherene Loi, Erika Hamilton, et al.
Pageof 15

Showing results (91-100 of 141) with videos related to

Sort By:
Pageof 15
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 1, 2010
Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancersGiampaolo Bianchini, Yuan Qi, Ricardo H Alvarez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 10, 2016
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice GuidelineLyndsay N Harris, Nofisat Ismaila, Lisa M McShane, et al.
JCO Precision Oncology|January 18, 2024
Prediction of Benefit From Adjuvant Pertuzumab by 80-Gene Signature in the APHINITY (BIG 4-11) TrialIan E Krop, Lorenza Mittempergher, Joseph N Paulson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2022
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline UpdateFabrice Andre, Nofisat Ismaila, Kimberly H Allison, et al.
Journal of the National Cancer Institute|December 31, 2010
Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancerTakayuki Iwamoto, Giampaolo Bianchini, Daniel Booser, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 9, 2016
Plasma ESR1 Mutations and the Treatment of Estrogen Receptor-Positive Advanced Breast CancerCharlotte Fribbens, Ben O'Leary, Lucy Kilburn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2005
Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancerRoman Rouzier, Lajos Pusztai, Suzette Delaloge, et al.
British Journal of Cancer|January 5, 2024
p4EBP1 staining predicts outcome in ER-positive endocrine-resistant metastatic breast cancer patients treated with everolimus and exemestaneHélène Vanacker, Isabelle Treilleux, Camille Schiffler, et al.
Autophagy|October 29, 2015
Combined evaluation of LC3B puncta and HMGB1 expression predicts residual risk of relapse after adjuvant chemotherapy in breast cancerSylvain Ladoire, Frédérique Penault-Llorca, Laura Senovilla, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 8, 2026
DESTINY-Breast08: a phase 1b study of trastuzumab deruxtecan in combination with other anticancer therapies in patients with HER2-low metastatic breast cancerKomal Jhaveri, Sherene Loi, Erika Hamilton, et al.
Pageof 15